Related Experiment Videos
Candida endocarditis in a premature infant
1Department of Pediatrics, University of Debrecen, Debrecen, Hungary. mogyorosyg@gyermek.dote.hu
Journal of Perinatal Medicine
|December 29, 2000
Summary
This case report details a fatal Candida albicans endocarditis in a premature infant despite fluconazole treatment. It highlights the need for vigilant monitoring of systemic candidiasis in neonates, even with antifungal therapy.
Area of Science:
- Neonatal Medicine
- Infectious Diseases
- Cardiology
Background:
- Invasive candidiasis is rare in neonates.
- Endocarditis is an uncommon but serious complication of invasive fungal infections.
- Premature infants are particularly vulnerable to systemic infections.
Observation:
- A very low birth weight infant (780g) developed Candida albicans endocarditis.
- The infant had no structural heart defects and no central venous catheter.
- Endocarditis occurred despite treatment with parenteral fluconazole.
Findings:
- Echocardiography confirmed the diagnosis of endocarditis.
- The infant succumbed to the infection on the 40th day of life.
- This represents a previously unreported case of Candida endocarditis in a fluconazole-treated premature infant.
Implications:
- Systemic candidiasis in premature infants requires intensive monitoring.
- Antifungal therapy may not always prevent severe complications like endocarditis.
- Early diagnosis and management are critical for improving outcomes in neonatal fungal infections.